Stop jumping across PubMed, Clinical Trials, Patents, and Omics databases. OIP Discovery® unifies, cleans, and structures the data and turn them into Scientific Intelligence.

 

Far more than a database, it is a connected scientific & artificial intelligence platform that centralizes, structures, and cross-links scientific and regulatory information to provide a 360° actionable view of the research landscape. Its mission is clear: speed up discovery and drive better strategic decision-making from R&D to clinical development for regulatory affairs, academia, and business development.

 

A Single Gateway to Global Scientific and Clinical Knowledge

With OIP Discovery®, teams no longer need to navigate PubMed, ClinicalTrials.gov, FDA, EMA portals, patent databases, or fragmented omics repositories one by one: instead, the platform continuously aggregates, cleans, normalizes, and updates trusted biomedical sources (NCBI/NIH, Orphanet, HPO, Ensembl, RxNorm, UMLS, EMBL-EBI…) into a single, traceable workspace, where AI agents can surface weak signals, emerging opportunities, and decision-ready insights across publications, trials, genes, variants, biomarkers, molecules and patents.

 

The platform provides:

• A unified entry point to major scientific, clinical, and regulatory sources
• Structured, comparable, and reliable data
• Intuitive search by molecule, gene, disease, publication, or clinical trial
• Automatic connections between R&D, clinical, regulatory, and business insights
• Real-time tracking of new publications, emerging signals, unmet needs, and market shifts

The impact?
Immediate time savings, better visibility on gene-molecule-disease connection, lower operational complexity for research, and faster strategic decision making.

 

Use Case #1 — R&D: Accelerating Biomarker Identification

Identifying new biomarkers is one of the most essential and time-consuming steps in drug discovery. Researchers must analyze thousands of publications, clinical trials, regulatory updates, and multi-omics datasets to identify promising signals.

Without a dedicated platform, this means:

• Weeks spent collecting and consolidating fragmented data
• Manual searches through numerous public reference databases
• High risk of missing a relevant study, biomarker, or regulatory guideline

OIP Discovery® transforms this process completely.

With a single query, R&D teams can explore:

• Emerging biomarkers published in the latest scientific literature
• Ongoing clinical trials using those biomarkers as endpoints
• Investigators, KOLs, and research centers most active in the related field
• Regulatory decisions and validated protocols involving these markers

Potential outcome: 

A task that once required several weeks can now be completed in minutes, enabling teams to:

• Faster shortlisting of biomarker candidates
• higher confidence in the evidence
• clearer prioritization for validation and assay development
• Identify strategic research partners
• Reallocate resources to the strongest scientific opportunities

Ultimately, OIP Discovery® frees researchers from manual data mining, allowing them to focus on what matters most: scientific interpretation, innovation, and therapeutic impact.

 

Use Case #2 — Academia: Faster, Stronger Scientific Writing

For academic researchers, literature reviews and scientific writing are essential, yet incredibly time-consuming. Searching, validating, and cross-checking sources often takes longer than the actual writing process.

With OIP Discovery®, a researcher can instantly retrieve:

• The most recent and relevant publications
• Associated clinical trials worldwide
• Regulatory insights linked to targeted therapies
• A clear structured view of all related information

This means:

• Gaining several days or even weeks of work
• Stronger scientific narratives
• Reducing the risk of bias or missing key articles
• Using reliable, continuously updated sources

OIP Discovery® becomes a scientific accelerator, supporting literature reviews, thesis writing, teaching materials, and research projects.

 

Use Case #3 — Clinical Development: Optimizing Clinical Trial Strategy

Designing a robust clinical trial protocol is critical and often risky. A single missing comparator, endpoint, or methodological detail can compromise regulatory approval or investor confidence.

Traditionally, clinical teams must manually analyze dozens of similar trials across multiple registries.

With OIP Discovery®, a biotech developing an oncology therapy can instantly:

• Compare its protocol to existing trials
• Identify the most validated endpoints
• Analyze successful study designs
• Map key investigators and research centers
• Track regulatory expectations in real time

Potential outcome:
A clearer, more confident, and more competitive clinical strategy reducing both operational risk and time to approval.

Use Case #4 — Hospitals & Regulatory Affairs: Accelerating Access to Innovation

Hospitals, particularly in oncology, pediatrics, and rare diseases, need rapid access to international regulatory data to support early access programs and therapeutic decisions.

Instead of consulting FDA, EMA, MHRA, PMDA and others one by one, OIP Discovery® enables teams to:

• Track global drug approvals in real time
• Compare indications between regulatory agencies
• Identify access gaps between countries
• Strengthen early-access requests with validated evidence

This accelerates:

• Medical decisions
• Access to innovative therapies
• Reduction of inequalities in patient care

OIP Discovery® becomes a strategic ally for hospitals and regulatory teams, turning regulatory complexity into medical opportunity.

 

Use Case #5 — Business Development: Anticipating Market Movements

In pharma and biotech, competitive advantage depends on the ability to detect emerging trends early.

OIP Discovery® empowers BD teams to:

• Track clinical development trends
• Identify new mechanisms of action
• Monitor price movements and new SKUs
• Detect emerging therapeutic areas
• Map KOLs and potential partners

Potential outcome:
The ability to detect unmet medical needs (care gaps) earlier, propose strategic partnerships, and make stronger investment decisions backed by consolidated data.

OIP Discovery® shifts BD teams from a reactive to a proactive posture enabling them to shape the market rather than follow it.

 

From Raw Data to Strategic Scientific Intelligence

Across all use cases, one message is clear:
OIP Discovery® is not just another database. It is a scientific & artificial intelligence platform designed to transform complexity into strategic clarity.

• For R&D, it accelerates biomarker discovery and research prioritization.
• For biotechs, it strengthens clinical protocols and investor credibility.
• For academia, it reduces literature review time and improves scientific rigor.
• For hospitals, it accelerates access to innovation.
• For business development, it reveals emerging opportunities and competitive insights.

By centralizing, structuring, and connecting all major scientific and regulatory sources, OIP Discovery® provides a transversal, actionable, and continuously updated view of global research.

In a world where each discovery, each trial, and each regulatory decision can shape the future of medicine, OIP Discovery® brings a crucial advantage:
more agility, more clarity, and more strategic impact.

📩 Want to see how OIP Discovery® can accelerate your research and decision-making?
Request a personalized demo: contact@tekkare.com